The intersection of COVID-19 and cancer: signaling pathways and treatment implications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The intersection of COVID-19 and cancer: signaling pathways and treatment implications
Authors
Keywords
-
Journal
Molecular Cancer
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-17
DOI
10.1186/s12943-021-01363-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunological alternation in COVID-19 patients with cancer and its implications on mortality
- (2021) Guangyao Cai et al. OncoImmunology
- Risk of COVID ‐19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
- (2021) Nikolai Klebanov et al. ONCOLOGIST
- Selinexor for the treatment of multiple myeloma
- (2020) Klaus Podar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection
- (2020) Ana Pertejo-Fernandez et al. LUNG CANCER
- Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer
- (2020) Dan Pu et al. MEDICINE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- COVID-19 is Out of Proportion in African Americans. This Will Come as No Surprise…
- (2020) Mona N. Fouad et al. AMERICAN JOURNAL OF MEDICINE
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
- (2020) M. Montopoli et al. ANNALS OF ONCOLOGY
- Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
- (2020) J.-M. Michot et al. ANNALS OF ONCOLOGY
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
- (2020) L. Zhang et al. ANNALS OF ONCOLOGY
- Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
- (2020) H. Miyashita et al. ANNALS OF ONCOLOGY
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
- (2020) Pierre Bost et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
- (2020) Zhuo Zhou et al. Cell Host & Microbe
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
- (2020) Hong-Yi Zheng et al. Cellular & Molecular Immunology
- NKG2A and COVID-19: another brick in the wall
- (2020) Luca Antonioli et al. Cellular & Molecular Immunology
- Using IL‐2R/lymphocytes for predicting the clinical progression of patients with COVID‐19
- (2020) H. Hou et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
- (2020) Toshio Hirano et al. IMMUNITY
- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
- (2020) Yang Cao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The many faces of the anti-COVID immune response
- (2020) Santosha A. Vardhana et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID‐19
- (2020) Yong Gao et al. JOURNAL OF MEDICAL VIROLOGY
- Focus on the Crosstalk Between COVID-19 and Urogenital Systems
- (2020) Zhang-song Wu et al. JOURNAL OF UROLOGY
- Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
- (2020) Jeff P Sharman et al. LANCET
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- SARS-CoV-2 and viral sepsis: observations and hypotheses
- (2020) Hui Li et al. LANCET
- Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
- (2020) Kunyu Yang et al. LANCET ONCOLOGY
- COVID-19 in persons with haematological cancers
- (2020) Wenjuan He et al. LEUKEMIA
- Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
- (2020) Mingfeng Liao et al. NATURE MEDICINE
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- African American children are at higher risk for COVID‐19 infection
- (2020) Sindhura Bandi et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study
- (2020) Dan Sun et al. World Journal of Pediatrics
- Drug treatment options for the 2019-new coronavirus (2019-nCoV)
- (2020) Hongzhou Lu BioScience Trends
- Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers
- (2020) Jia Luo et al. Cancer Discovery
- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
- (2020) Vikas Mehta et al. Cancer Discovery
- TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?
- (2020) Konrad H. Stopsack et al. Cancer Discovery
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database
- (2020) Alessandro Ceschi et al. Frontiers in Pharmacology
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury
- (2020) Yingxia Liu et al. National Science Review
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
- (2020) Jing Yu et al. JAMA Oncology
- Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
- (2020) Jian-Min Jin et al. Frontiers in Public Health
- Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation
- (2020) Jiawei Chen et al. AGING CELL
- C5aR deficiency attenuates the breast cancer development via the p38/p21 axis
- (2020) Jian Chen et al. Aging-US
- COVID-19 in patients with lung cancer
- (2020) J. Luo et al. ANNALS OF ONCOLOGY
- Type 1 interferons as a potential treatment against COVID-19
- (2020) Erwan Sallard et al. ANTIVIRAL RESEARCH
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
- (2020) Dennis McGonagle et al. AUTOIMMUNITY REVIEWS
- A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia
- (2020) Walter Fiedler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Lymphocyte Subset Counts in COVID ‐19 Patients: A Meta‐Analysis
- (2020) Wei Huang et al. CYTOMETRY PART A
- Exportin 1 inhibition as antiviral therapy
- (2020) Md. Hafiz Uddin et al. DRUG DISCOVERY TODAY
- Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
- (2020) Benjamin Israelow et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- (2020) Marina Chiara Garassino et al. LANCET ONCOLOGY
- The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
- (2020) F. La Rosée et al. LEUKEMIA
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- A single-cell atlas of the peripheral immune response in patients with severe COVID-19
- (2020) Aaron J. Wilk et al. NATURE MEDICINE
- Determinants of COVID-19 disease severity in patients with cancer
- (2020) Elizabeth V. Robilotti et al. NATURE MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The CoV-2 outbreak: how hematologists could help to fight Covid-19
- (2020) Sara Galimberti et al. PHARMACOLOGICAL RESEARCH
- Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway
- (2020) Qinhai Ma et al. PHARMACOLOGICAL RESEARCH
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm
- (2020) Chuang Guo et al. Nature Communications
- Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
- (2020) David J Pinato et al. Cancer Discovery
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- (2020) Francesco Passamonti et al. Lancet Haematology
- Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
- (2020) Mark Roschewski et al. Science Immunology
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- (2020) Jeong Seok Lee et al. Science Immunology
- COVID-19 and Cancer: Current Challenges and Perspectives
- (2020) Ziad Bakouny et al. CANCER CELL
- SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19
- (2020) Lars F. Westblade et al. CANCER CELL
- Cytokine Storms in Cancer and COVID-19
- (2020) Casmir Turnquist et al. CANCER CELL
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET ONCOLOGY
- The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19
- (2020) Amir Hossein Mansourabadi et al. LIFE SCIENCES
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics
- (2020) Trent M. Woodruff et al. TRENDS IN IMMUNOLOGY
- Immune Checkpoints in Viral Infections
- (2020) Huiming Cai et al. Viruses-Basel
- Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19
- (2020) Qirui Guo et al. Cell Host & Microbe
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials
- (2020) Laura Pasin et al. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
- Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
- (2019) Michael R. Cook et al. JAMA Oncology
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- Dose-ranging and cohort-expansion study of monalizumab(IPH2201) in advanced gynecologic malignancies:A trial of the Canadian Cancer Trials Group (CCTG):IND221
- (2019) Anna V Tinker et al. CLINICAL CANCER RESEARCH
- IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
- (2019) Rudragouda Channappanavar et al. JOURNAL OF CLINICAL INVESTIGATION
- The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy
- (2019) Yu Wang et al. Frontiers in Immunology
- Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma
- (2019) Ajai Chari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
- (2019) Meghan A. Rice et al. Frontiers in Oncology
- Repurposing of gamma interferon via inhalation delivery
- (2018) Gerald C. Smaldone ADVANCED DRUG DELIVERY REVIEWS
- Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
- (2018) Dan T. Vogl et al. JOURNAL OF CLINICAL ONCOLOGY
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- KPT-330, a potent and selective CRM1 inhibitor, exhibits anti-inflammation effects and protection against sepsis
- (2018) Ming Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Dual Nature of Type I and Type II Interferons
- (2018) Amanda J. Lee et al. Frontiers in Immunology
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- Acalabrutinib and its use in treatment of chronic lymphocytic leukemia
- (2018) Yasir Khan et al. Future Oncology
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer
- (2017) Marcela Moisés Maluf Sanguinete et al. IMMUNOLOGICAL INVESTIGATIONS
- Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV Working Group
- (2017) Thomas S. Uldrick et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
- (2017) L.L. Bu et al. JOURNAL OF DENTAL RESEARCH
- Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab recativity
- (2017) Ryota Tanaka et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
- (2017) Francesco Passamonti et al. LANCET ONCOLOGY
- PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
- (2017) V Atsaves et al. LEUKEMIA
- Severe cytokine release syndrome in a patient receiving PD-1-directed therapy
- (2017) Seth J. Rotz et al. PEDIATRIC BLOOD & CANCER
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Type I Interferon in Chronic Virus Infection and Cancer
- (2017) Laura M. Snell et al. TRENDS IN IMMUNOLOGY
- Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era
- (2017) Edward M. Behrens et al. Arthritis & Rheumatology
- Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
- (2017) Roy Fleischmann et al. Arthritis & Rheumatology
- JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer
- (2017) Chunwan Lu et al. OncoImmunology
- Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications
- (2017) Martina Musella et al. OncoImmunology
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- A Nuclear Attack on Traumatic Brain Injury: Sequestration of Cell Death in the Nucleus
- (2016) Naoki Tajiri et al. CNS Neuroscience & Therapeutics
- IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
- (2016) Thomas A Mace et al. GUT
- Chronic Blockade of the Androgen Receptor Abolishes Age-Dependent Increases in Blood Pressure in Female Growth-Restricted RatsNovelty and Signficance
- (2016) John Henry Dasinger et al. HYPERTENSION
- The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
- (2016) Nan Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors
- (2016) Albiruni R. Abdul Razak et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma
- (2016) Mrinal M. Gounder et al. JOURNAL OF CLINICAL ONCOLOGY
- Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report
- (2016) Marc Uemura et al. Journal of Hematology & Oncology
- Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta
- (2016) J. S. Mishra et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- Baricitinib in Patients with Refractory Rheumatoid Arthritis
- (2016) Mark C. Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
- (2016) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma
- (2016) JIAN GAO et al. ONCOLOGY REPORTS
- Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection
- (2016) Olivia Perwitasari et al. PLoS One
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis
- (2016) Omar Abdel-Rahman et al. Therapeutic Advances in Respiratory Disease
- Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling
- (2015) F. Conforti et al. CLINICAL CANCER RESEARCH
- Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer
- (2015) Freya A. Goumas et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary
- (2015) Nozomu Yanaihara et al. MOLECULAR CARCINOGENESIS
- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
- (2015) Alessandro M. Vannucchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma
- (2015) TEPPEI JINNO et al. ONCOLOGY REPORTS
- Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels
- (2015) Tomofumi Miura et al. PANCREAS
- Type I Interferon: Understanding Its Role in HIV Pathogenesis and Therapy
- (2015) Steven E. Bosinger et al. Current HIV/AIDS Reports
- The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis
- (2015) Qing Chang et al. NEOPLASIA
- Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells
- (2014) Ammad Farooqi et al. Cancer Cell International
- Androgen Receptor CAG Repeat Polymorphism and Risk of TMPRSS2:ERG-Positive Prostate Cancer
- (2014) S. Yoo et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
- (2014) S. K. Vadrevu et al. CANCER RESEARCH
- Immune Activation Driven by CTLA-4 Blockade Augments Viral Replication at Mucosal Sites in Simian Immunodeficiency Virus Infection
- (2014) V. Cecchinato et al. JOURNAL OF IMMUNOLOGY
- Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
- (2014) Lanxi Song et al. Journal of Thoracic Oncology
- Targeting heat shock proteins in metastatic castration-resistant prostate cancer
- (2014) Arun A. Azad et al. Nature Reviews Urology
- The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
- (2014) J. M. Lucas et al. Cancer Discovery
- The role of intratumoral and systemic IL-6 in breast cancer
- (2013) Christine Dethlefsen et al. BREAST CANCER RESEARCH AND TREATMENT
- p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
- (2013) Abdul M. Mondal et al. JOURNAL OF CLINICAL INVESTIGATION
- Modification of the Association Between Obesity and Lethal Prostate Cancer by TMPRSS2:ERG
- (2013) Andreas Pettersson et al. JNCI-Journal of the National Cancer Institute
- TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium
- (2013) S. Bertram et al. JOURNAL OF VIROLOGY
- IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
- (2013) Miao-Fen Chen et al. Molecular Cancer
- The role of IL-6 in the radiation response of prostate cancer
- (2013) Chun-Te Wu et al. Radiation Oncology
- Viral Subversion of the Nuclear Pore Complex
- (2013) Valerie Le Sage et al. Viruses-Basel
- Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
- (2013) Bastian Hatesuer et al. PLoS Pathogens
- Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
- (2012) R. Lapalombella et al. BLOOD
- Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
- (2012) Chin Hao Chang et al. INTERNATIONAL JOURNAL OF CANCER
- Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
- (2012) J Etchin et al. LEUKEMIA
- Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts
- (2012) Stephanie Bertram et al. PLoS One
- Genome-wide DNA Methylation Events in TMPRSS2–ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a Hypermethylation
- (2012) Stefan T. Börno et al. Cancer Discovery
- Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
- (2011) Marina Lesina et al. CANCER CELL
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
- (2011) Zoran Culig et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Nosocomial infections in patients with cancer
- (2009) Mini Kamboj et al. LANCET ONCOLOGY
- Androgen receptor and androgen-dependent gene expression in lung
- (2009) Laura Mikkonen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma
- (2008) JM Lucas et al. JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now